⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026
The Dispatch

NSE

Aarti Pharmalabs LimitedAARTIPHARM

Aarti Pharmalabs Limited is an Indian pharmaceutical company engaged in the manufacturing and distribution of APIs and formulations.

Key productsAPIs, Formulations
GeographyIndia, Export markets including Middle East, Africa, Europe
CompetitorsDr Reddy's Laboratories, Cipla, Sun Pharmaceutical Industries

AI-generated overview — verify before relying on it.

Net institutional flow

+₹88.3 Cr

Institutional buyers

3 in / 2 out

High-impact filings

0 · tilt Neutral

Next corporate action

Interim Dividend - Rs 1.50 Per Share

ex 2026-02-16

Competitive landscape — the read

vs most-traded names
Institutional money is backing AARTIPHARM hardest (+₹88.3 Cr net). AARTIPHARM leads this set on institutional accumulation.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1AARTIPHARMThis+₹88.3 Cr15————
2MTNL+₹41.3 Cr331————
3ATALREAL+₹7.4 Cr363————
4GATECH+₹0.4 Cr298————
5IRMENERGY−₹2.2 Cr356————
6QUADFUTURE−₹9 Cr571————
7MOBIKWIK−₹150.9 Cr975————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

  • • [object Object]
  • • [object Object]

Weaknesses

  • • [object Object]
  • • [object Object]

Opportunities

  • • [object Object]
  • • [object Object]

Threats

  • • [object Object]
  • • [object Object]

AI-generated from our data — verify before relying on it.

Timeline — AARTIPHARM day by day

  1. 2026-06-12FilingChandrakant Vallabhaji Gogri has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Shareholding Disclosure
  2. 2026-02-16ActionInterim Dividend - Rs 1.50 Per ShareDividend
  3. 2025-09-19BulkSELL · ₹42.7 CrBNP PARIBAS FINANCIAL MARKETS
  4. 2025-09-19BulkBUY · ₹45.1 CrNORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL
  5. 2025-09-19BulkSELL · ₹55.8 CrSAFECHEM ENTERPRISES PRIVATE LIMITED
  6. 2025-09-19BulkBUY · ₹48.5 CrVANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIF
  7. 2025-09-19BulkBUY · ₹52.2 CrVANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
  8. 2025-09-15ActionDividend - Rs 2.50 Per ShareDividend
  9. 2025-02-14ActionInterim Dividend - Rs 2.50 Per ShareDividend
  10. 2025-02-07BulkBUY · ₹63 CrGRAVITON RESEARCH CAPITAL LLP
  11. 2025-02-07BulkSELL · ₹63 CrGRAVITON RESEARCH CAPITAL LLP
  12. 2025-02-06BulkBUY · ₹60.4 CrGRAVITON RESEARCH CAPITAL LLP
  13. 2025-02-06BulkSELL · ₹60.3 CrGRAVITON RESEARCH CAPITAL LLP
  14. 2024-12-27BulkSELL · ₹52.4 CrGRAVITON RESEARCH CAPITAL LLP
  15. 2024-12-27BulkBUY · ₹52.4 CrGRAVITON RESEARCH CAPITAL LLP
  16. 2024-12-26BulkBUY · ₹30 CrABAKKUS ASSET MANAGER PRIVATE LIMITED
  17. 2024-12-26BulkBUY · ₹31.6 CrABAKKUS ASSET MANAGER PRIVATE LIMITED
  18. 2024-12-26BulkSELL · ₹28.6 CrORCHID FAMILY TRUST
  19. 2024-12-26BulkSELL · ₹28.9 CrTULIP FAMILY TRUST
  20. 2024-07-31ActionDividend - Re 1 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF →

Bulk & block deals

1M3M6M1Y2YAll

15 deals · 2024-12-26 → 2025-09-19

DateCounterpartyInvestor typeSideValue
2025-09-19BNP PARIBAS FINANCIAL MARKETSHNI / otherSELL₹42.7 Cr
2025-09-19NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBALInstitutionBUY₹45.1 Cr
2025-09-19SAFECHEM ENTERPRISES PRIVATE LIMITEDHNI / otherSELL₹55.8 Cr
2025-09-19VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFInstitutionBUY₹48.5 Cr
2025-09-19VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDInstitutionBUY₹52.2 Cr
2025-02-07GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹63 Cr
2025-02-07GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹63 Cr
2025-02-06GRAVITON RESEARCH CAPITAL LLPProp / churnBUY₹60.4 Cr
2025-02-06GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹60.3 Cr
2024-12-27GRAVITON RESEARCH CAPITAL LLPProp / churnSELL₹52.4 Cr

15 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

News & chatter on AARTIPHARM

RSS News

0

No recent news.

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.